Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Novikov

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancers|September 28, 2023
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 MacrophagesIseulys Richert, Paul Berchard, Lhorra Abbes, et al.
Analytical Chemistry|December 15, 2004
Matrix-implanted laser desorption/ionization mass spectrometryAlexey Novikov, Martine Caroff, Serge Della-Negra, et al.
Minerva Urology and Nephrology|November 18, 2021
Enucleation vs. vaporization of benign prostatic hyperplasia: a head-to-head comparison of the various outcomes and complications. A systematic review and meta-analysisMark Taratkin, Anastasia Shpikina, Andrey Morozov, et al.
Innate Immunity|October 16, 2013
Complete Bordetella avium, Bordetella hinzii and Bordetella trematum lipid A structures and genomic sequence analyses of the loci involved in their modificationsAlexey Novikov, Nita R Shah, Sami AlBitar-Nehme, et al.
Frontiers in Immunology|May 24, 2023
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical modelsKamel Chettab, Chantel Fitzsimmons, Alexey Novikov, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancers|September 28, 2023
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 MacrophagesIseulys Richert, Paul Berchard, Lhorra Abbes, et al.
Analytical Chemistry|December 15, 2004
Matrix-implanted laser desorption/ionization mass spectrometryAlexey Novikov, Martine Caroff, Serge Della-Negra, et al.
Minerva Urology and Nephrology|November 18, 2021
Enucleation vs. vaporization of benign prostatic hyperplasia: a head-to-head comparison of the various outcomes and complications. A systematic review and meta-analysisMark Taratkin, Anastasia Shpikina, Andrey Morozov, et al.
Innate Immunity|October 16, 2013
Complete Bordetella avium, Bordetella hinzii and Bordetella trematum lipid A structures and genomic sequence analyses of the loci involved in their modificationsAlexey Novikov, Nita R Shah, Sami AlBitar-Nehme, et al.
Frontiers in Immunology|May 24, 2023
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical modelsKamel Chettab, Chantel Fitzsimmons, Alexey Novikov, et al.
Pageof 4